ASO GROUP Ltd bought a new stake in Ralliant Corporation (NYSE:RAL – Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 73,074 shares of the company’s stock, valued at approximately $3,720,000. Ralliant makes up approximately 1.5% of ASO GROUP Ltd’s investment portfolio, making the stock its 11th largest position. ASO GROUP Ltd owned approximately 0.06% of Ralliant as of its most recent SEC filing.
A number of other hedge funds also recently modified their holdings of the business. Vanguard Group Inc. lifted its holdings in shares of Ralliant by 10.7% in the third quarter. Vanguard Group Inc. now owns 14,589,423 shares of the company’s stock valued at $637,995,000 after purchasing an additional 1,415,327 shares in the last quarter. Viking Global Investors LP purchased a new stake in shares of Ralliant in the second quarter valued at $257,200,000. State Street Corp acquired a new position in shares of Ralliant in the second quarter worth $213,096,000. Invesco Ltd. increased its stake in shares of Ralliant by 90.1% in the third quarter. Invesco Ltd. now owns 3,871,690 shares of the company’s stock worth $169,309,000 after acquiring an additional 1,835,128 shares during the last quarter. Finally, Norges Bank acquired a new position in shares of Ralliant in the fourth quarter worth $124,687,000.
Wall Street Analyst Weigh In
A number of research firms have recently weighed in on RAL. Royal Bank Of Canada upped their price target on shares of Ralliant from $47.00 to $64.00 and gave the stock a “sector perform” rating in a research note on Wednesday, May 13th. Barclays upped their price target on shares of Ralliant from $52.00 to $67.00 and gave the stock an “overweight” rating in a research note on Wednesday, May 13th. Wall Street Zen downgraded shares of Ralliant from a “buy” rating to a “hold” rating in a research note on Sunday, May 31st. Oppenheimer upped their price target on shares of Ralliant from $50.00 to $65.00 and gave the stock an “outperform” rating in a research note on Wednesday, May 13th. Finally, Citigroup upped their price target on shares of Ralliant from $51.00 to $70.00 and gave the stock a “buy” rating in a research note on Wednesday, May 13th. Seven equities research analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $67.30.
Ralliant Trading Up 5.1%
Ralliant stock opened at $65.66 on Friday. The company has a debt-to-equity ratio of 0.73, a current ratio of 1.61 and a quick ratio of 1.05. The company has a market capitalization of $7.35 billion and a price-to-earnings ratio of -6.00. Ralliant Corporation has a one year low of $37.27 and a one year high of $65.91. The company’s fifty day moving average price is $52.57 and its two-hundred day moving average price is $49.71.
Ralliant (NYSE:RAL – Get Free Report) last posted its earnings results on Tuesday, May 12th. The company reported $0.57 EPS for the quarter, topping the consensus estimate of $0.49 by $0.08. The firm had revenue of $534.60 million for the quarter. Ralliant had a negative net margin of 58.55% and a positive return on equity of 12.49%. Ralliant’s revenue for the quarter was up 11.0% compared to the same quarter last year. Ralliant has set its FY 2026 guidance at 2.530-2.690 EPS and its Q2 2026 guidance at 0.580-0.640 EPS. On average, analysts forecast that Ralliant Corporation will post 2.64 earnings per share for the current fiscal year.
Ralliant Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 23rd. Stockholders of record on Monday, June 8th will be given a $0.05 dividend. This represents a $0.20 annualized dividend and a dividend yield of 0.3%. The ex-dividend date of this dividend is Monday, June 8th. Ralliant’s dividend payout ratio (DPR) is currently -1.83%.
Ralliant Company Profile
Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.
The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.
Featured Articles
- Five stocks we like better than Ralliant
- Microsoft Just Gave Investors 3 Dates They Can’t Afford to Ignore
- NVIDIA’s Outlook Gains Momentum: Stock Price to Follow
- The World Cup Is Coming—These 3 Stocks Could Cash In
- Spotify’s “North Star” Outlook Was Music to Investors Ears
Want to see what other hedge funds are holding RAL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ralliant Corporation (NYSE:RAL – Free Report).
Receive News & Ratings for Ralliant Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ralliant and related companies with MarketBeat.com's FREE daily email newsletter.
